Literature DB >> 20464522

Physician effectiveness in interventions to improve cardiovascular medication adherence: a systematic review.

Sarah L Cutrona1, Niteesh K Choudhry, Margaret Stedman, Amber Servi, Joshua N Liberman, Troyen Brennan, Michael A Fischer, M Alan Brookhart, William H Shrank.   

Abstract

BACKGROUND: Medications for the prevention and treatment of cardiovascular disease save lives but adherence is often inadequate. The optimal role for physicians in improving adherence remains unclear.
OBJECTIVE: Using existing evidence, we set the goal of evaluating the physician's role in improving medication adherence.
DESIGN: We conducted systematic searches of English-language peer-reviewed publications in MEDLINE and EMBASE from 1966 through 12/31/2008. SUBJECTS AND
INTERVENTIONS: We selected randomized controlled trials of interventions to improve adherence to medications used for preventing or treating cardiovascular disease or diabetes. MAIN MEASURES: Articles were classified as either (1) physician "active"-a physician participated in designing or implementing the intervention; (2) physician "passive"-physicians treating intervention group patients received patient adherence information while physicians treating controls did not; or (3) physicians noninvolved. We also identified studies in which healthcare professionals helped deliver the intervention. We did a meta-analysis of the studies involving healthcare professionals to determine aggregate Cohen's D effect sizes (ES). KEY
RESULTS: We identified 6,550 articles; 168 were reviewed in full, 82 met inclusion criteria. The majority of all studies (88.9%) showed improved adherence. Physician noninvolved studies were more likely (35.0% of studies) to show a medium or large effect on adherence compared to physician-involved studies (31.3%). Among interventions requiring a healthcare professional, physician-noninvolved interventions were more effective (ES 0.47; 95% CI 0.38-0.56) than physician-involved interventions (ES 0.25; 95% CI 0.21-0.29; p < 0.001). Among physician-involved interventions, physician-passive interventions were marginally more effective (ES 0.29; 95% CI 0.22-0.36) than physician-active interventions (ES 0.23; 95% CI 0.17-0.28; p = 0.2).
CONCLUSIONS: Adherence interventions utilizing non-physician healthcare professionals are effective in improving cardiovascular medication adherence, but further study is needed to identify the optimal role for physicians.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20464522      PMCID: PMC2955481          DOI: 10.1007/s11606-010-1387-9

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  85 in total

1.  The effects of postal and telephone reminders on compliance with pravastatin therapy in a national registry: results of the first myocardial infarction risk reduction program.

Authors:  R M Guthrie
Journal:  Clin Ther       Date:  2001-06       Impact factor: 3.393

2.  A randomized trial of special packaging of antihypertensive medications.

Authors:  L A Becker; K Glanz; E Sobel; J Mossey; S L Zinn; K A Knott
Journal:  J Fam Pract       Date:  1986-04       Impact factor: 0.493

3.  Pharmacist involvement in primary care improves hypertensive patient clinical outcomes.

Authors:  Phayom Sookaneknun; Robert M E Richards; Jaratbhan Sanguansermsri; Chai Teerasut
Journal:  Ann Pharmacother       Date:  2004-11-02       Impact factor: 3.154

4.  Randomised equivalence trial comparing three month and six month follow up of patients with hypertension by family practitioners.

Authors:  Richard V Birtwhistle; Marshall S Godwin; M Dianne Delva; R Ian Casson; Miu Lam; Susan E MacDonald; Rachelle Seguin; Lucia Rühland
Journal:  BMJ       Date:  2004-01-15

5.  Self-recording of blood pressure in the management of hypertension.

Authors:  A L Johnson; D W Taylor; D L Sackett; C W Dunnett; A G Shimizu
Journal:  Can Med Assoc J       Date:  1978-11-04       Impact factor: 8.262

6.  Screening, treatment and adherence to treatment for hypertension.

Authors:  J Takala
Journal:  Scand J Prim Health Care       Date:  1983       Impact factor: 2.581

7.  A randomized trial of direct-to-patient communication to enhance adherence to beta-blocker therapy following myocardial infarction.

Authors:  David H Smith; Judith M Kramer; Nancy Perrin; Richard Platt; Douglas W Roblin; Kimberly Lane; Michael Goodman; Winnie W Nelson; Xiuhai Yang; Stephen B Soumerai
Journal:  Arch Intern Med       Date:  2008-03-10

8.  Increasing compliance. Patient-operated hypertension groups.

Authors:  D G Nessman; J E Carnahan; C A Nugent
Journal:  Arch Intern Med       Date:  1980-11

9.  Helping patients with type 2 diabetes mellitus make treatment decisions: statin choice randomized trial.

Authors:  Audrey J Weymiller; Victor M Montori; Lesley A Jones; Amiram Gafni; Gordon H Guyatt; Sandra C Bryant; Teresa J H Christianson; Rebecca J Mullan; Steven A Smith
Journal:  Arch Intern Med       Date:  2007-05-28

10.  Improvement of medication compliance in uncontrolled hypertension.

Authors:  R B Haynes; D L Sackett; E S Gibson; D W Taylor; B C Hackett; R S Roberts; A L Johnson
Journal:  Lancet       Date:  1976-06-12       Impact factor: 79.321

View more
  19 in total

1.  Helping our patients to adhere to chronic medications: a new arrow for the quiver.

Authors:  William H Shrank
Journal:  J Gen Intern Med       Date:  2011-12       Impact factor: 5.128

Review 2.  Medication adherence outcomes of 771 intervention trials: Systematic review and meta-analysis.

Authors:  Vicki S Conn; Todd M Ruppar
Journal:  Prev Med       Date:  2017-03-16       Impact factor: 4.018

3.  Comparative cost-effectiveness of interventions to improve medication adherence after myocardial infarction.

Authors:  Kouta Ito; William H Shrank; Jerry Avorn; Amanda R Patrick; Troyen A Brennan; Elliot M Antman; Niteesh K Choudhry
Journal:  Health Serv Res       Date:  2012-09-21       Impact factor: 3.402

Review 4.  Medication adherence among pediatric patients with sickle cell disease: a systematic review.

Authors:  Kathleen E Walsh; Sarah L Cutrona; Patricia L Kavanagh; Lori E Crosby; Chris Malone; Katie Lobner; David G Bundy
Journal:  Pediatrics       Date:  2014-11-17       Impact factor: 7.124

5.  Recommendations for Providers on Person-Centered Approaches to Assess and Improve Medication Adherence.

Authors:  Hayden B Bosworth; Stephen P Fortmann; Jennifer Kuntz; Leah L Zullig; Phil Mendys; Monika Safford; Shobha Phansalkar; Tracy Wang; Maureen H Rumptz
Journal:  J Gen Intern Med       Date:  2017-01       Impact factor: 5.128

Review 6.  Medication adherence interventions that target subjects with adherence problems: Systematic review and meta-analysis.

Authors:  Vicki S Conn; Todd M Ruppar; Maithe Enriquez; Pam Cooper
Journal:  Res Social Adm Pharm       Date:  2015-06-15

7.  Change of walking distance in intermittent claudication: impact on inflammation, oxidative stress and mononuclear cells: a pilot study.

Authors:  Jörn F Dopheide; Martin Scheer; Christopher Doppler; Viviane Obst; Pamela Stein; Markus Vosseler; Nico Abegunewardene; Tommaso Gori; Thomas Münzel; Andreas Daiber; Markus P Radsak; Christine Espinola-Klein
Journal:  Clin Res Cardiol       Date:  2015-03-15       Impact factor: 5.460

8.  Key barriers to medication adherence in survivors of strokes and transient ischemic attacks.

Authors:  Ian M Kronish; Michael A Diefenbach; Donald E Edmondson; L Alison Phillips; Kezhen Fei; Carol R Horowitz
Journal:  J Gen Intern Med       Date:  2013-01-04       Impact factor: 5.128

Review 9.  Meta-analyses of Theory Use in Medication Adherence Intervention Research.

Authors:  Vicki S Conn; Maithe Enriquez; Todd M Ruppar; Keith C Chan
Journal:  Am J Health Behav       Date:  2016-03

10.  Medication Adherence in Older Adults: A Qualitative Study.

Authors:  Elizabeth W Holt; Ariane L Rung; Kyla A Leon; Catherine Firestein; Marie A Krousel-Wood
Journal:  Educ Gerontol       Date:  2014-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.